Announcements Trials
Browse Landscape

Status

Terminated 1No longer available 1Completed 1Available 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Suspensions 2Powders 2trametinib 1talquetamab 1taletrectinib 1sotorasib 1ruxolitinib 1revumenib 1omburtamab I-131 1leronlimab 1gallium maltolate 1dabrafenib 1ceritinib 1capmatinib 1asparaginase erwinia chrysanthemi recombinant 1apalutamide 1Standard of Care 1Paclitaxel 1Nivolumab 1HMPL-013 1Docetaxel 1Asparaginase 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × leronlimab × 1 year × Clear all
NCT04313075 2025-07-15

A Compassionate Use Study of Leronlimab in Breast Cancer

CytoDyn, Inc.

No longer available
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡